TMZ monotherapy increased tumor infiltration of CD4+ and CD8+ T-cells in the Nhe1 Con mice by ~ 2-fold (Fig. 5D, F), but, not in the Nhe1 KO mice. The gene discussed is CD4; the disease is neoplasm.